The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Positive response of a primary leiomyosarcoma of the breast following salvage hyperthermia and pazopanib

  • Lee, Sun Young (Department of Radiation Oncology, Chonbuk National University Hospital, Chonbuk National University Medical School) ;
  • Lee, Na-Ri (Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute, Chonbuk National University Hospital)
  • Received : 2015.07.27
  • Accepted : 2015.11.09
  • Published : 2018.03.01
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Karabulut Z, Akkaya H, Moray G. Primary leiomyosarcoma of the breast: a case report. J Breast Cancer 2012;15:124-127. https://doi.org/10.4048/jbc.2012.15.1.124
  2. van der Graaf WT, Blay JY, Chawla SP, et al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2012;379:1879-1886. https://doi.org/10.1016/S0140-6736(12)60651-5
  3. Issels RD, Lindner LH, Verweij J, et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol 2010;11:561-570. https://doi.org/10.1016/S1470-2045(10)70071-1
  4. Sleijfer S, Gorlia T, Lamers C, et al. Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC- STBSG study. Br J Cancer 2012;107:639-645. https://doi.org/10.1038/bjc.2012.328
  5. Pietzner K, Schmuck RB, Fotopoulou C, et al. Long term combination treatment with bevacizumab, pegylated liposomal doxorubicin and regional abdominal hyperthermia in platinum refractory ovarian cancer: a case report and review of the literature. Anticancer Res 2011;31:2675-2677.

Cited by

  1. Primary breast leiomyosarcoma in male - A case report vol.4, pp.18, 2018, https://doi.org/10.15342/ijms.v4ir.166
  2. Hematuria induced by combination regorafenib and hyperthermia - a radiation recall effect vol.36, pp.1, 2018, https://doi.org/10.1080/02656736.2019.1687941
  3. Quo Vadis Oncological Hyperthermia (2020)? vol.10, pp.None, 2018, https://doi.org/10.3389/fonc.2020.01690
  4. Synergistic effects of pazopanib and hyperthermia against uterine leiomyosarcoma growth mediated by downregulation of histone acetyltransferase 1 vol.98, pp.8, 2020, https://doi.org/10.1007/s00109-020-01888-w
  5. Rare case of primary leiomyosarcoma of the breast treated with wide local excision and planned cosmetic breast reduction surgery vol.13, pp.11, 2018, https://doi.org/10.1136/bcr-2020-236013
  6. “Oncothermia” (Modulated electro-hyperthermia) : - Present status and future development - vol.37, pp.1, 2018, https://doi.org/10.3191/thermalmed.37.1
  7. A rare etiology of a large tumoral mass of the breast - Case report primary leiomyosarcoma and osteosarcoma of the breast vol.78, pp.None, 2021, https://doi.org/10.1016/j.ijscr.2020.12.050
  8. Leiomyosarcoma Breast with Extensive Metastasis: a Case Report vol.83, pp.suppl2, 2018, https://doi.org/10.1007/s12262-020-02242-7